105
Views
4
CrossRef citations to date
0
Altmetric
Original Article

High consumption of tetracyclines for acne treatment among young Danish adults

, , &
Pages 808-812 | Received 08 Mar 2016, Accepted 16 Jun 2016, Published online: 06 Jul 2016

References

  • Dawson AL, Dellavalle RP. Acne vulgaris. BMJ. 2013;346:f2634.
  • Yentzer BA, Hick J, Reese EL, et al. Acne vulgaris in the United States: a descriptive epidemiology. Cutis. 2010;86:94–99.
  • Purdy S, de Berker D. Acne. BMJ. 2006;333:949.
  • Nast A, Dreno B, Bettoli V, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26:1–29.
  • Lomholt HB, Kolmos HJ. [Treatment of acne with a focus on antibiotics and resistance: how can we reduce the consumption]. Rationel Farmakoterapi October 2014, IRF, Denmark.
  • Del Rosso JQ. Oral doxycycline in the management of acne vulgaris: current perspectives on clinical use and recent findings with a new double-scored small tablet formulation. J Clin Aesthet Dermatol. 2015;8:19–26.
  • Simonart T, Dramaix M, de Maertelaer V. Efficacy of tetracyclines in the treatment of acne vulgaris: a review. Br J Dermatol. 2008;158:208–216.
  • Ross JI, Snelling AM, Carnegie E, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol. 2003;148:467–478.
  • Eady EA, Gloor M, Leyden JJ. Propionibacterium acnes resistance: a worldwide problem. Dermatology (Basel). 2003;206:54–56.
  • Leyden JJ, McGinley KJ, Cavalieri S, et al. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol. 1983;8:41–45.
  • Espersen F. Resistance to antibiotics used in dermatological practice. Br J Dermatol. 1998;139:4–8.
  • Valtonen MV, Valtonen VV, Salo OP, et al. The effect of long term tetracycline treatment for acne vulgaris on the occurrence of R factors in the intestinal flora of man. Br J Dermatol. 1976;95:311–316.
  • Adams SJ, Cunliffe WJ, Cooke EM. Long-term antibiotic therapy for acne vulgaris: effects on the bowel flora of patients and their relatives. J Invest Dermatol. 1985;85:35–37.
  • Møller JK, Bak AL, Stenderup A, et al. Changing patterns of plasmid-mediated drug resistance during tetracycline therapy. Antimicrob Agents Chemother. 1977;11:388–391.
  • DANMAP. 2012: Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark 2012; 2013.
  • Coenen S, Adriaenssens N, Versporten A, et al. European surveillance of antimicrobial consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997–2009). J Antimicrob Chemother. 2011;66:vi57–vi70.
  • Jensen US, Bjerrum L. [Notable increase in the consumption of antibiotics in general practice]. Ugeskr Laeg. 2011;173:2853–2856.
  • Kuhn KG, Hammerum AM, Jensen US. The association between demographic factors and increased antimicrobial consumption in Denmark 2001–2010. Scand J Inf Dis. 2014;46: 599–604.
  • WHO. ATC Structure and Principles. WHO Collaborating Centre for Drug Statistics Methodology, 2014 [Internet]. Available from: www.who.int.
  • Danish Health Authority. [Vejledning om ordination af antibiotika]. Copenhagen (Denmark): Danish Health Authority; 2012.
  • DANMAP. 2013: Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark 2013; 2014.
  • Kinney MA, Yentzer BA, Fleischer AB, Jr., et al. Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance? J Drugs Dermatol. 2010;9:519–524.
  • Lee YH, Liu G, Thiboutot DM, et al. A retrospective analysis of the duration of oral antibiotic therapy for the treatment of acne among adolescents: investigating practice gaps and potential cost-savings. J Am Acad Dermatol. 2014;71:70–76.
  • Mobacken H, Oprica C, Berg M. [New treatment strategy in acne vulgaris. Antibiotic prescription must be limited]. Lakartidningen. 2012;109:1085–1089.
  • Eady AE, Cove JH, Layton AM. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers. Am J Clin Dermatol. 2003;4:813–831.
  • Dreno B, Bettoli V, Ochsendorf F, et al. European recommendations on the use of oral antibiotics for acne. Eur J Dermatol. 2004;14:391–399.
  • Muhammad M, Rosen T. A controversial proposal: no more antibiotics for acne! Skin Therapy Lett. 2013;18:1–4.
  • Dreno B, Thiboutot D, Gollnick H, et al. Antibiotic stewardship in dermatology: limiting antibiotic use in acne. Eur J Dermatol. 2014;24:330–334.
  • Thiboutot D, Dreno B, Gollnick H, et al. A call to limit antibiotic use in acne. J Drugs Dermatol. 2013;12:1331–1332.
  • Cole A. GPs feel pressurised to prescribe unnecessary antibiotics, survey finds. BMJ. 2014;349:g5238.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.